Global Overactive Bladder Drug Market Size, Status and Forecast 2025

Published: Apr, 2018 | Pages: 105 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report studies the global Overactive Bladder Drug market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Overactive Bladder Drug market by companies, region, type and end-use industry.

This report focuses on the global top players, covered
Astellas Pharma, Inc. (Japan)
Pfizer, Inc. (U.S.)
Teva Pharmaceutical Industries Limited (Israel)
Allergan, Plc (Ireland)
Medtronic plc (Ireland)
Mylan N.V. (U.S.)
Endo International plc (Ireland)
Hisamitsu Pharmaceutical Co., Inc. (Japan)
Sanofi (France)
Apotex, Inc. (Canada)
Cogentix Medical, Inc. (U.S.)
Aurobindo Pharma Limited (India)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Anticholinergics
Solifenacin
Oxybutynin
Darifenacin
Fesoterodine
Tolterodine
Trospium
Others

Market segment by Application, Overactive Bladder Drug can be split into
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity

The study objectives of this report are:
To study and forecast the market size of Overactive Bladder Drug in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Overactive Bladder Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Overactive Bladder Drug Manufacturers
Overactive Bladder Drug Distributors/Traders/Wholesalers
Overactive Bladder Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Overactive Bladder Drug market, by end-use.
Detailed analysis and profiles of additional market players.

 Table of Contents

Global Overactive Bladder Drug Market Size, Status and Forecast 2025
1 Industry Overview of Overactive Bladder Drug
    1.1  Overactive Bladder Drug Market Overview
        1.1.1 Overactive Bladder Drug Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Overactive Bladder Drug Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 Europe
        1.2.3 China
        1.2.4 Japan
        1.2.5 Southeast Asia
        1.2.6 India
    1.3 Overactive Bladder Drug Market by Type
        1.3.1 Anticholinergics
        1.3.2 Solifenacin
        1.3.3 Oxybutynin
        1.3.4 Darifenacin
        1.3.5 Fesoterodine
        1.3.6 Tolterodine
        1.3.7 Trospium
        1.3.8 Others
    1.4 Overactive Bladder Drug Market by End Users/Application
        1.4.1 Idiopathic Bladder Overactivity
        1.4.2 Neurogenic Bladder Overactivity

2 Global Overactive Bladder Drug Competition Analysis by Players
    2.1 Overactive Bladder Drug Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Astellas Pharma, Inc. (Japan)
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.2 Pfizer, Inc. (U.S.)
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.3 Teva Pharmaceutical Industries Limited (Israel)
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.4 Allergan, Plc (Ireland)
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.5 Medtronic plc (Ireland)
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.6 Mylan N.V. (U.S.)
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.7 Endo International plc (Ireland)
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.8 Hisamitsu Pharmaceutical Co., Inc. (Japan)
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.9 Sanofi (France)
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.10 Apotex, Inc. (Canada)
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Overactive Bladder Drug Revenue (Million USD) (2013-2018)
    3.11 Cogentix Medical, Inc. (U.S.)
    3.12 Aurobindo Pharma Limited (India)

4 Global Overactive Bladder Drug Market Size by Type and Application (2013-2018)
    4.1 Global Overactive Bladder Drug Market Size by Type (2013-2018)
    4.2 Global Overactive Bladder Drug Market Size by Application (2013-2018)
    4.3 Potential Application of Overactive Bladder Drug in Future
    4.4 Top Consumer/End Users of Overactive Bladder Drug

5 United States Overactive Bladder Drug Development Status and Outlook
    5.1 United States Overactive Bladder Drug Market Size (2013-2018)
    5.2 United States Overactive Bladder Drug Market Size and Market Share by Players (2013-2018)
    5.3 United States Overactive Bladder Drug Market Size by Application (2013-2018)

6 Europe Overactive Bladder Drug Development Status and Outlook
    6.1 Europe Overactive Bladder Drug Market Size (2013-2018)
    6.2 Europe Overactive Bladder Drug Market Size and Market Share by Players (2013-2018)
    6.3 Europe Overactive Bladder Drug Market Size by Application (2013-2018)

7 China Overactive Bladder Drug Development Status and Outlook
    7.1 China Overactive Bladder Drug Market Size (2013-2018)
    7.2 China Overactive Bladder Drug Market Size and Market Share by Players (2013-2018)
    7.3 China Overactive Bladder Drug Market Size by Application (2013-2018)

8 Japan Overactive Bladder Drug Development Status and Outlook
    8.1 Japan Overactive Bladder Drug Market Size (2013-2018)
    8.2 Japan Overactive Bladder Drug Market Size and Market Share by Players (2013-2018)
    8.3 Japan Overactive Bladder Drug Market Size by Application (2013-2018)

9 Southeast Asia Overactive Bladder Drug Development Status and Outlook
    9.1 Southeast Asia Overactive Bladder Drug Market Size (2013-2018)
    9.2 Southeast Asia Overactive Bladder Drug Market Size and Market Share by Players (2013-2018)
    9.3 Southeast Asia Overactive Bladder Drug Market Size by Application (2013-2018)

10 India Overactive Bladder Drug Development Status and Outlook
    10.1 India Overactive Bladder Drug Market Size (2013-2018)
    10.2 India Overactive Bladder Drug Market Size and Market Share by Players (2013-2018)
    10.3 India Overactive Bladder Drug Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Overactive Bladder Drug Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Overactive Bladder Drug Revenue and Growth Rate (2018-2025)
        11.1.2 Europe Overactive Bladder Drug Revenue and Growth Rate (2018-2025)
        11.1.3 China Overactive Bladder Drug Revenue and Growth Rate (2018-2025)
        11.1.4 Japan Overactive Bladder Drug Revenue and Growth Rate (2018-2025)
        11.1.5 Southeast Asia Overactive Bladder Drug Revenue and Growth Rate (2018-2025)
        11.1.6 India Overactive Bladder Drug Revenue and Growth Rate (2018-2025)
    11.2 Global Overactive Bladder Drug Market Size (Value) by Type (2018-2025)
    11.3 Global Overactive Bladder Drug Market Size by Application (2018-2025)

12 Overactive Bladder Drug Market Dynamics
    12.1 Overactive Bladder Drug Market Opportunities
    12.2 Overactive Bladder Drug Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Overactive Bladder Drug Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Overactive Bladder Drug Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Global Overactive Bladder Drug Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Overactive Bladder Drug Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Overactive Bladder Drug Market Share by Regions (2013-2018)
    Figure United States Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Europe Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Overactive Bladder Drug Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Overactive Bladder Drug Revenue Market Share by Type in 2017
    Figure Anticholinergics Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Solifenacin Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Oxybutynin Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Darifenacin Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Fesoterodine Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Tolterodine Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Trospium Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Overactive Bladder Drug Market Share by Application in 2017
    Figure Overactive Bladder Drug Market Size (Million USD) and Growth Rate in Idiopathic Bladder Overactivity (2013-2018)
    Figure Overactive Bladder Drug Market Size (Million USD) and Growth Rate in Neurogenic Bladder Overactivity (2013-2018)
    Figure Overactive Bladder Drug Market Size (Million USD) and Growth Rate in Applications 3 (2013-2018)
    Table Overactive Bladder Drug Market Size (Million USD) by Players (2013-2018)
    Figure Overactive Bladder Drug Market Size Share by Players in 2013
    Figure Overactive Bladder Drug Market Size Share by Players in 2017
    Table Astellas Pharma, Inc. (Japan) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Astellas Pharma, Inc. (Japan) (2013-2018)
    Figure Astellas Pharma, Inc. (Japan) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Pfizer, Inc. (U.S.) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Pfizer, Inc. (U.S.) (2013-2018)
    Figure Pfizer, Inc. (U.S.) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Teva Pharmaceutical Industries Limited (Israel) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Teva Pharmaceutical Industries Limited (Israel) (2013-2018)
    Figure Teva Pharmaceutical Industries Limited (Israel) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Allergan, Plc (Ireland) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Allergan, Plc (Ireland) (2013-2018)
    Figure Allergan, Plc (Ireland) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Medtronic plc (Ireland) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Medtronic plc (Ireland) (2013-2018)
    Figure Medtronic plc (Ireland) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Mylan N.V. (U.S.) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Mylan N.V. (U.S.) (2013-2018)
    Figure Mylan N.V. (U.S.) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Endo International plc (Ireland) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Endo International plc (Ireland) (2013-2018)
    Figure Endo International plc (Ireland) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Hisamitsu Pharmaceutical Co., Inc. (Japan) (2013-2018)
    Figure Hisamitsu Pharmaceutical Co., Inc. (Japan) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Sanofi (France) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Sanofi (France) (2013-2018)
    Figure Sanofi (France) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Apotex, Inc. (Canada) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Apotex, Inc. (Canada) (2013-2018)
    Figure Apotex, Inc. (Canada) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Cogentix Medical, Inc. (U.S.) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Cogentix Medical, Inc. (U.S.) (2013-2018)
    Figure Cogentix Medical, Inc. (U.S.) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Aurobindo Pharma Limited (India) Basic Information List
    Table Overactive Bladder Drug Business Revenue (Million USD) of Aurobindo Pharma Limited (India) (2013-2018)
    Figure Aurobindo Pharma Limited (India) Overactive Bladder Drug Business Revenue Market Share (2013-2018)
    Table Global Overactive Bladder Drug Market Size (Million USD) by Product (2013-2018)
    Figure Global Overactive Bladder Drug Revenue Market Share (%) by Product (2013-2018)
    Figure Global Overactive Bladder Drug Market Share by Product in 2017
    Table Global Overactive Bladder Drug Market Size by Application (2013-2018)
    Figure Global Overactive Bladder Drug Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Overactive Bladder Drug
    Figure United States Overactive Bladder Drug Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Overactive Bladder Drug Market Size (Million USD) by Players (2013-2018)
    Figure United States Overactive Bladder Drug Market Size Share by Players in 2013
    Figure United States Overactive Bladder Drug Market Size Share by Players in 2017
    Table United States Overactive Bladder Drug Market Size by Application (2013-2018)
    Figure United States Overactive Bladder Drug Revenue Market Share (%) by Application (2013-2018)
    Figure United States Overactive Bladder Drug Market Size Share by Application in 2017
    Figure Europe Overactive Bladder Drug Market Size (Million USD) and Growth Rate (2013-2018)
    Table Europe Overactive Bladder Drug Market Size (Million USD) by Players (2013-2018)
    Figure Europe Overactive Bladder Drug Market Size Share by Players in 2013
    Figure Europe Overactive Bladder Drug Market Size Share by Players in 2017
    Table Europe Overactive Bladder Drug Market Size by Application (2013-2018)
    Figure Europe Overactive Bladder Drug Revenue Market Share (%) by Application (2013-2018)
    Figure Europe Overactive Bladder Drug Market Size Share by Application in 2017
    Figure China Overactive Bladder Drug Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Overactive Bladder Drug Market Size (Million USD) by Players (2013-2018)
    Figure China Overactive Bladder Drug Market Size Share by Players in 2013
    Figure China Overactive Bladder Drug Market Size Share by Players in 2017
    Table China Overactive Bladder Drug Market Size by Application (2013-2018)
    Figure China Overactive Bladder Drug Revenue Market Share (%) by Application (2013-2018)
    Figure China Overactive Bladder Drug Market Size Share by Application in 2017
    Figure Japan Overactive Bladder Drug Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Overactive Bladder Drug Market Size (Million USD) by Players (2013-2018)
    Figure Japan Overactive Bladder Drug Market Size Share by Players in 2013
    Figure Japan Overactive Bladder Drug Market Size Share by Players in 2017
    Table Japan Overactive Bladder Drug Market Size by Application (2013-2018)
    Figure Japan Overactive Bladder Drug Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Overactive Bladder Drug Market Size Share by Application in 2017
    Figure Southeast Asia Overactive Bladder Drug Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Overactive Bladder Drug Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Overactive Bladder Drug Market Size Share by Players in 2013
    Figure Southeast Asia Overactive Bladder Drug Market Size Share by Players in 2017
    Table Southeast Asia Overactive Bladder Drug Market Size by Application (2013-2018)
    Figure Southeast Asia Overactive Bladder Drug Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Overactive Bladder Drug Market Size Share by Application in 2017
    Figure India Overactive Bladder Drug Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Overactive Bladder Drug Market Size (Million USD) by Players (2013-2018)
    Figure India Overactive Bladder Drug Market Size Share by Players in 2013
    Figure India Overactive Bladder Drug Market Size Share by Players in 2017
    Table India Overactive Bladder Drug Market Size by Application (2013-2018)
    Figure India Overactive Bladder Drug Revenue Market Share (%) by Application (2013-2018)
    Figure India Overactive Bladder Drug Market Size Share by Application in 2017
    Figure Global Overactive Bladder Drug Market Size and Growth Rate (2018-2025)
    Table Global Overactive Bladder Drug Market Size (Million USD) by Regions (2018-2025)
    Figure Global Overactive Bladder Drug Market Size Share (2018-2025)
    Figure Global Overactive Bladder Drug Market Size Share by Regions in 2025
    Figure United States Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Europe Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Overactive Bladder Drug Market Size (Million USD) by Type (2018-2025)
    Figure Global Overactive Bladder Drug Market Size Share by Type in 2018
    Figure Global Overactive Bladder Drug Market Size Share by Type in 2025
    Table Global Overactive Bladder Drug Market Size (Million USD) by Application (2018-2025)
    Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2018
    Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2025

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.